We have dozens of randomized clinical trials that concluded there aren’t tangible prognostic benefits from coronary revascularization in some patients with single or multi-vessel coronary artery disease who are suffering from cardiomyopathy. Such lack of benefit may be explained by non-explored presence of co-incidental non-ischemic cardiomyopathy. Thus, the same patient may have both ischaemic and […]

There is no denying that the main target during PCI are significant proximal lesions in the three main coronary vessels (LAD, RCA and LCX), but sometimes we are faced with ostial significant lesions in sizable side branches that shouldn’t be overlooked (especially, OM and diagonals). We are focusing here on MEDINA 0,0,1 ostial bifurcational affection […]

In spite that drug-eluting stents (DES), particularly newer generations,  are the gold standard in treating significant coronary artery lesions, there is at least 2-4% risk of target lesion failure (TLF) per year, in the form of in-stent restenosis (ISR). The risk of In-stent restenosis (ISR) is invariably higher when you are obliged to use smaller […]

A lost part of a CVP was extracted percutanously

Unusual presentation! devil in details Our patient, female 50 years old with no previous significant medical history. Two days before the presentation show was waked at night with unbearable epigastric pain and vomiting, so she went to the ER, ER she received IV PPI and referred for ECG Her ECG at the ER shows diffuse [...]